Lately, I’ve found myself in more candid conversations with customers, suppliers, and industry peers about a reality we can no longer ignore: the widening impact of the conflict involving Iran on global supply chains.
And I’ll be honest, this one feels different.
We’ve lived through disruption before. But what we’re seeing now is something more complex. Energy markets, raw material availability, logistics networks, and geopolitical tension are no longer operating in isolation; they’re converging at the same time, amplifying one another and creating a new level of uncertainty that is harder to predict and even harder to absorb.
For manufacturers in the medical device space, that convergence isn’t theoretical. It’s already showing up in planning cycles, input costs, and long-term sourcing decisions.
The Ripple Effect Is Real, and It’s Accelerating
At first, many people think this conflict is mainly about oil. But in our field of medical devices, fluid bags, flexible packaging, it goes much deeper.
When energy prices rise, everything else does too. Plastics, films, and polymers, the backbone of medical fluid bags, depend on petrochemical supply chains. As these materials become more expensive or harder to find, manufacturing costs rise quickly.
“The longer this uncertainty lasts, the more pressure manufacturers face to maintain operations without sacrificing quality or compliance.”
We’re also seeing higher freight and insurance costs, longer shipping times, and rerouted shipments as important routes like the Strait of Hormuz become less reliable. What worries many of us most is that this isn’t just about higher prices, it’s about whether supplies will be available at all.
There are already warnings that disruptions could affect not only oil but also key materials such as plastics, chemicals, and other industrial inputs, leading to shortages and higher prices.
Medical Supply Chains Are Feeling the Pressure
In medical manufacturing, there is very little room for error.
We’re already seeing early signs of stress in pharmaceutical and medical supply chains, including delays in key ingredients and higher packaging and distribution costs. Even as effects unfold, the longer this uncertainty lasts, the more pressure manufacturers face to maintain operations without sacrificing quality or compliance.
That balance is not easy to achieve.
Inflation Is No Longer a Maybe. It’s a Given.
Inflation is one of the most common themes I’m hearing and seeing.
Global supply chain pressures are already at their highest levels in years, mainly because of energy shocks and disrupted logistics. Economists warn that this conflict may affect inflation more quickly than overall growth, as supply constraints drive up costs across industries.
“Uncertainty is no longer the exception, it’s the environment we work in.”
For manufacturers like us, this means we must manage rising input costs while still providing the reliability our customers expect.
A Shift in the Global Plastics Equation
One dynamic that doesn’t get talked about enough, but is becoming increasingly important, is how this disruption is reshaping the global plastics and feedstock landscape in uneven ways.
While much of the focus has been on inflation and shortages, there’s also an emerging structural shift beneath the surface. North America, for example, is comparatively well-positioned in this environment. The region benefits from abundant natural gas supply, which serves as a key feedstock advantage for plastics production. That energy base provides a level of stability and insulation that many other regions simply don’t have right now.
Asia tells a very different story.
Many Asian manufacturing economies, particularly China and its neighboring supply bases, are more heavily reliant on imported feedstocks and oil-based inputs for plastics production. With portions of those supply routes under strain and reports of force majeure declarations across parts of the region, the system is facing real pressure at the source, not just at the logistics layer.
“While much of the focus has been on inflation and shortages, there’s also an emerging structural shift beneath the surface.”
When you combine that with the lingering effects of post-COVID realignment and ongoing tariff environments, it creates a compounding challenge: a region that has long been the backbone of global manufacturing is now navigating both upstream material constraints and downstream cost volatility at the same time.
From where I sit, this doesn’t just represent disruption, it represents a rebalancing. And for companies in the medical device space, it reinforces an important truth: resilience is no longer just about managing demand or logistics. It’s about understanding where in the world your materials are truly most stable and building supply strategies that reflect that reality.
So What Do We Do About It?
This is where I believe mindset is most important.
At Vonco, our approach to resilience is unique: we embed proactive strategies tailored to the medical manufacturing sector into our systems well before disruptions arise. We focus on solutions like rapid product line shifts, specialized material sourcing expertise, and dedicated compliance teams to ensure continuity where others struggle to adapt.
That means:
- Designing for flexibility from the start: We consider alternative materials, dual sourcing, and scalability early in product development.
- Strengthening supplier partnerships: In times like these, strong relationships always outperform transactional ones.
- Investing in visibility and planning: Knowing where risks exist, whether in materials, logistics, or regulations, lets us act early instead of reacting late.
- Avoiding the panic trap: Stockpiling and overcorrecting can sometimes make things less stable. Smart, targeted risk mitigation is what really keeps supply steady.
Resilience Is No Longer Optional
If there’s one lesson from what we’re experiencing now, it’s this: Uncertainty is no longer the exception, it’s the environment we work in.
Geopolitical conflict, material volatility, and regulatory changes are now constant forces that demand a proactive, sophisticated approach to risk. In medical manufacturing, the stakes are higher than in most industries.
Ultimately, supply chain resilience ensures that patients and providers receive the critical medical products they rely on, regardless of global challenges.
For Vonco, resilience isn’t a backup plan, it’s essential to how we operate.
Sources:
https://www.weforum.org/stories/2026/04/beyond-oil-lng-commodities-impacted-closure-hormuz-strait/
https://www.packagingdive.com/news/iran-war-packaging-effects-disruption-oil-aluminum-plastics/815156/
https://aami.org/news/war-iran-impacts-medical-device-supply-chains-oil-aluminum/
https://www.businessinsider.com/professor-predicts-iran-war-supply-shock-for-global-markets-oil-2026-4/
https://cen.acs.org/business/petrochemicals/Strait-Hormuz-closure-hits-Asias/104/web/2026/03